<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Cynata Therapeutics Kicks Off Patient Enrollment
Image Overlay - Cynata Therapeutics Kicks Off Patient Enrollment

Cynata Therapeutics Kicks Off Patient Enrollment

September 14, 2020

Cynata Therapeutics Kicks Off Patient Enrollment

Biotech company Cynata Therapeutics has begun enrolling patients in their mesenchymal COVID-19 (MEND) trial. The study will explore the efficacy of mesenchymal stem cells in adults diagnosed with severe cases of the virus. “MSCs represent a very promising therapeutic approach to a range of important diseases,” commented company CEO Ross MacDonald. Yourway can transport, store, and distribute even the most challenging drug products, making us the ideal logistics partner provider for all clinical trial needs.

Back to Index
Media

Upcoming Events

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Media

Articles

Case study: Coordinating a complex intercontinental shipment on a short timeline

Open chat
Come chat with us!
Hello! How can I help you?